Prognostic Value of Soluble Death Receptor Ligands in Patients with Transitional Cell Carcinoma of Bladder.

Date publication

mai 2018

Journal

Urologia internationalis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BETTAIEB Ali

Tous les auteurs :
Ben Bahria-Sediki I, Chebil M, Sampaio C, Martel-Frachet V, Cherif M, Zermani R, Rammeh S, Ben Ammar Gaaied A, Bettaieb A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/29719304

Résumé

The activation of Fas/Fas ligand (FasL) and DR4-DR5/tumor necrosis factor-related-apoptosis-inducing ligand (TRAIL) pathways in cancer cells triggers apoptosis. The objective of this study was to investigate the prognostic value of soluble FasL (sFasL) and soluble (sTRAIL) in the serum of patients with bladder cancer.

Mots clés

Cell death, Serum soluble Fas ligand, Serum soluble tumor necrosis factor-related-apoptosis-inducing ligand, death receptors, Transitional cell carcinoma of bladder

Référence

Urol. Int.. 2018 May 2;:1-9